For example, resistance to EGFR inhibition in GBM was previously suggested to be due to activation of IGF1R [84] or MET [85] pathways, and signaling from these pathways results in AKT activation [84], [86], [87]. The gene discussed is IGF1R; the disease is glioblastoma.